144 related articles for article (PubMed ID: 20557836)
1. 10 Years CESAR Anticancer Drug Research - The 7th CESAR Annual Meeting 2009. Preface.
Edler L; Sehrt D; Scheulen ME
Int J Clin Pharmacol Ther; 2010 Jul; 48(7):435-9. PubMed ID: 20557836
[No Abstract] [Full Text] [Related]
2. Preface. Combining clinical, translational and basic cancer drug research: the 2008 CESAR annual meeting.
Brockmoeller J; Sehrt D; Scheulen ME
Int J Clin Pharmacol Ther; 2009 Jan; 47(1):30-2. PubMed ID: 19203530
[No Abstract] [Full Text] [Related]
3. Standard Operating Procedures for clinical trials of the CESAR Central European Society for Anticancer Drug Research--EWIV. Preface.
Gastl G; Dittrich C
Onkologie; 2003 Oct; 26 Suppl 6():IX. PubMed ID: 23570176
[No Abstract] [Full Text] [Related]
4. Extended abstracts of the annual meeting of the Working Group for Pharmacology in Oncology and Hematology (APOH) of the Central European Society for Anticancer Drug Research (CESAR), Vienna, Austria, 2005.
Int J Clin Pharmacol Ther; 2005 Dec; 43(12):566-608. PubMed ID: 16625725
[No Abstract] [Full Text] [Related]
5. Editorial: translational medicine is promoting cross-talk of inter discipline.
Yu Y
Anticancer Agents Med Chem; 2013 Feb; 13(2):193-4. PubMed ID: 22934704
[No Abstract] [Full Text] [Related]
6. Extended abstracts of the Annual Symposium of the Working Group for Pharmacology in Oncology and Hematology (APOH) of the Central European Society for Anticancer Drug Research (CESAR). June 12-14, 2008. Göttingen, Germany.
Int J Clin Pharmacol Ther; 2009 Jan; 47(1):30-64. PubMed ID: 19385009
[No Abstract] [Full Text] [Related]
7. Lessons Learned from Two Decades of Anticancer Drugs.
Liu Z; Delavan B; Roberts R; Tong W
Trends Pharmacol Sci; 2017 Oct; 38(10):852-872. PubMed ID: 28709554
[TBL] [Abstract][Full Text] [Related]
8. Editorial. Approaches to personalized medicine in oncology--the 9th Annual Meeting of CESAR in Greifswald.
Ritter C; Sehrt D; Jaehde U
Int J Clin Pharmacol Ther; 2012 Jan; 50(1):53-4. PubMed ID: 22192647
[No Abstract] [Full Text] [Related]
9. SOP 01: Clinical investigations in CESAR.
Onkologie; 2003 Oct; 26 Suppl 6():1-4. PubMed ID: 23570177
[No Abstract] [Full Text] [Related]
10. Ubiquitin Drug Discovery & Diagnostics 2009 - First Annual Conference.
Marblestone JG
IDrugs; 2009 Dec; 12(12):750-3. PubMed ID: 19943215
[TBL] [Abstract][Full Text] [Related]
11. Annual meeting of CESAR in Tuebingen, Germany June 27-29, 2013.
von Pawel J; Schwab M; Sehrt D
Int J Clin Pharmacol Ther; 2014 Jan; 52(1):73. PubMed ID: 24403101
[No Abstract] [Full Text] [Related]
12. American Association for Cancer Research--100th Annual Meeting. New therapeutic developments: part 1. 18-22 April 2009, Denver, CO, USA.
Gale S; McGee V; Lee W
IDrugs; 2009 Jun; 12(6):331-4. PubMed ID: 19517308
[No Abstract] [Full Text] [Related]
13. The 8th annual meeting of CESAR in St. Gallen--novel therapeutic concepts in hemato-oncology.
Morant R; Sehrt D; Jaehde U
Int J Clin Pharmacol Ther; 2011 Jan; 49(1):58-9. PubMed ID: 21176728
[No Abstract] [Full Text] [Related]
14. American Association for Cancer Research 98th Annual Meeting. Anticancer agents - Part II.
Filson S
IDrugs; 2007 Jun; 10(6):359-61. PubMed ID: 17641994
[No Abstract] [Full Text] [Related]
15. Preface.
Prudhomme M
Anticancer Agents Med Chem; 2017; 17(1):3. PubMed ID: 28143384
[No Abstract] [Full Text] [Related]
16. American Association for Cancer Research--100th Annual Meeting. HDAC inhibitors, proteasome inhibitors and vascular disrupting agents. 18-22 April 2009, Denver, CO, USA.
Mitra AP
IDrugs; 2009 Jun; 12(6):339-41. PubMed ID: 19517310
[No Abstract] [Full Text] [Related]
17. American Association for Cancer Research 98th Annual Meeting. Anticancer agents - Part I.
Kneller S
IDrugs; 2007 Jun; 10(6):356-8. PubMed ID: 17641993
[No Abstract] [Full Text] [Related]
18. Reverse Translational Research of ABCG2 (BCRP) in Human Disease and Drug Response.
Brackman DJ; Giacomini KM
Clin Pharmacol Ther; 2018 Feb; 103(2):233-242. PubMed ID: 29023674
[TBL] [Abstract][Full Text] [Related]
19. Anticancer drug discovery in the future: an evolutionary perspective.
Ma X; Wang Z
Drug Discov Today; 2009 Dec; 14(23-24):1136-42. PubMed ID: 19800414
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle theories slowly turn into practice.
Bender E
Cancer Discov; 2011 Sep; 1(4):280. PubMed ID: 22586600
[No Abstract] [Full Text] [Related]
[Next] [New Search]
